Transgenic mice expressing IGF-1 are reported to present higher incidences of tumors in mammary glands while transgenic mice overexpressing human GH exhibit hepatic upregulation of GH-signaling mediators which lead to liver neoplasms [57]. The gene discussed is GH1; the disease is liver neoplasm.